Press Releases
"The 21st Century Brain Trust™," a coalition of four nonprofit organizations working to end Alzheimer's disease, took a $100,000 prize, out of submissions from more than 280 partnering organizations to the Sanofi US's Partners in Patient Health Collaborate | Activate Innovation Challenge.
The U.S. Food and Drug Administration (FDA) on November 18 approved the new drug application for aflibercept ophthalmic solution (trade name EYLEA), a new product for treatment of wet age-related macular degeneration (wet AMD). The action follows the unanimous recommendation of the drug's approval, issued last June by the FDA's Dermatologic and Ophthalmic Drugs Advisory Committee.
The American Health Assistance Foundation, a nonprofit organization funding innovative research through its Alzheimer's Disease Research (ADR) program, today announced that the number of scientists seeking ADR research grants through its annual application process increased by 33% this year.
The recent comments of the Rev. Pat Robertson on the 700 Club television program, and the ensuing media coverage of his statement that the spouse of a person with advanced Alzheimer's disease could consider divorce, have stirred a firestorm of passions and comments.
The American Health Assistance Foundation (AHAF) has joined forces with members of USAgainstAlzheimer's, the Alzheimer's Foundation of America, SeniorsforLiving.com, and the Crisis Prevention Institute to create #talkalz, a new TweetChat aimed at providing information and advice about Alzheimer's disease.
The FDA's Dermatologic and Ophthalmic Drugs Advisory Committee met on June 17 to review the new drug application for aflibercept ophthalmic solution (trade name EYLEA), a new product for treatment of wet age-related macular degeneration (wet AMD).
The American Health Assistance Foundation's (AHAF) Board of Directors elected two new members during its summer meeting in New York City: Judith F. Lee of Nantucket, MA, and June Kinoshita of Waltham, MA. The Board also selected Grace Frisone of New Orleans, LA, to be its new Vice Chair.
The American Health Assistance Foundation, a nonprofit organization with a history of funding cutting-edge research on age-related diseases, announced today that it has awarded 22 new grants totaling nearly $2.2 million to scientists worldwide who are studying glaucoma and macular degeneration. The two conditions are the leading causes of irreversible vision loss and blindness in the U.S.
The American Health Assistance Foundation, a nonprofit organization that funds innovative, early-stage research on Alzheimer's disease, today announced it has awarded 19 new grants, totaling more than $3.4 million, to scientists worldwide. Alzheimer's disease, a degenerative disorder that destroys brain function and eventually leads to death from complete brain failure, is the sixth leading cause of death in the U.S.
Stein Your Florist Co. will host a Spring Family Festival in support of Alzheimer's Disease Research, a program of the American Health Assistance Foundation, on Saturday 16 April (rain date Sunday 17 April) in the Mayfair neighborhood of Philadelphia.